Recursion Pharmaceuticals Inc (RXRX)
Who owns Recursion Pharmaceuticals Inc (RXRX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 97.8% of the shares are freely tradable; institutional investors hold 68.8%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 8.89 | 47,187,759 | +18.6 | 12/31/2025 |
| BlackRock Inc | 8.14 | 43,192,306 | +11.1 | 03/31/2026 |
| ARK Investment Management LLC | 7.58 | 40,212,769 | +7.8 | 03/31/2026 |
| State Street Corp | 5.37 | 28,490,638 | +12.5 | 03/31/2026 |
| Baillie Gifford & Co Limited. | 4.46 | 23,675,407 | -0.4 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.29 | 22,759,100 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.19 | 22,244,387 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Innovation ETF | 4.24 | 22,495,674 | +2.3 | 05/31/2026 |
| ARK Disruptive Innovation Full Composite | 4.23 | 22,432,199 | +9.3 | 03/31/2026 |
| State Street® SPDR® S&P® Biotech ETF | 3.49 | 18,523,524 | -0.6 | 05/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 7. Jul 2026 | Borgeson Blake | Director | Sell | 40,000 | 3.96 | 158,500 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.